Osteopore (Osx.Ax)

Osteopore (Osx.Ax) company information, Employees & Contact Information

We are the global leaders in regenerative solutions. Our bioresorbable implant is the first of its kind to be successfully developed and commercialized for surgical use. How does our technology work? Our implants help to heal bone naturally. They are used in surgeries to restore bone functions and dissolve over time, leaving only natural, healthy bone tissues. This reduces post-surgery complication rates significantly, compared to permanent implants. Why bioresorbable implants? Regenerative tech is rapidly revolutionizing the world as it enables new possibilities that would have otherwise been impossible with traditional methods. This includes restoring bodily functions so patients walk again or have confidence to live a normal life after traumatic injuries. Our products are trusted and used by surgeons across Asia, Europe, Australia, and the Americas. More about us on our website ↓

Company Details

Employees
23
Address
2 Tukang Innovation Grv, Medtech Hub,singapore
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Singapore, Singapore
Looking for a particular Osteopore (Osx.Ax) employee's phone or email?

Osteopore (Osx.ax) Questions

News

Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market - ABN Newswire

Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market ABN Newswire

ASX Runners: Lumos, Tali Resources, Osteopore, ClearVue & Evion - The Sydney Morning Herald

ASX Runners: Lumos, Tali Resources, Osteopore, ClearVue & Evion The Sydney Morning Herald

Top 10 at 11: ASX falls to start week as Osteopore gains Switzerland win - Stockhead

Top 10 at 11: ASX falls to start week as Osteopore gains Switzerland win Stockhead

Osteopore Full Year 2024 Earnings: AU$0.043 loss per share (vs AU$0.51 loss in FY 2023) - Yahoo Finance

Osteopore Full Year 2024 Earnings: AU$0.043 loss per share (vs AU$0.51 loss in FY 2023) Yahoo Finance

Osteopore eyes more collaborations to globalise regenerative implants - South China Morning Post

Osteopore eyes more collaborations to globalise regenerative implants South China Morning Post

Osteopore International Recognised for Transforming Healthcare With the 2016 Frost & Sullivan Singapore 3D Scaffolds Entrepreneurial Company of the Year Award - PR Newswire

Osteopore International Recognised for Transforming Healthcare With the 2016 Frost & Sullivan Singapore 3D Scaffolds Entrepreneurial Company of the Year Award PR Newswire

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure - News-Medical

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure News-Medical

Osteopore and UMC+ 3D print leg amputation preventive implant - 3D Printing Industry

Osteopore and UMC+ 3D print leg amputation preventive implant 3D Printing Industry

New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug - 美通社

New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug 美通社

Osteopore’s 3D regenerative implants could revolutionize orthopedic surgery - BioWorld MedTech

Osteopore’s 3D regenerative implants could revolutionize orthopedic surgery BioWorld MedTech

Singapore develops bioresorbable bone implant solution to prevent leg amputations - BioSpectrum Asia

Singapore develops bioresorbable bone implant solution to prevent leg amputations BioSpectrum Asia

Osteopore steps up global expansion in Brazilian craniofacial market - BiotechDispatch

Osteopore steps up global expansion in Brazilian craniofacial market BiotechDispatch

Osteopore granted European market approval for custom orthopaedic and cranial implants - smallcaps.com.au

Osteopore granted European market approval for custom orthopaedic and cranial implants smallcaps.com.au

Osteopore reaches dental implant development milestones - Australian Manufacturing Forum

Osteopore reaches dental implant development milestones Australian Manufacturing Forum

Case Study: Osteopore International’s bright future as a regenerative medicine leader - RSM Global

Case Study: Osteopore International’s bright future as a regenerative medicine leader RSM Global

Hot Stocks: Livium, 29Metals, Osteopore - Sharecafe

Hot Stocks: Livium, 29Metals, Osteopore Sharecafe

Osteopore partners with Magloy Tech to market new OrthoMag dissolvable implant - 3D Printing Industry

Osteopore partners with Magloy Tech to market new OrthoMag dissolvable implant 3D Printing Industry

Osteopore secures clearance for jawbone trial at Princess Alexandra Hospital - BiotechDispatch

Osteopore secures clearance for jawbone trial at Princess Alexandra Hospital BiotechDispatch

Osteopore makes ASX debut, plans to become leading producer of 3D-printed implants to promote bone regeneration - smallcaps.com.au

Osteopore makes ASX debut, plans to become leading producer of 3D-printed implants to promote bone regeneration smallcaps.com.au

Osteopore enhances strategic refocus with early cessation of dental grant project - BiotechDispatch

Osteopore enhances strategic refocus with early cessation of dental grant project BiotechDispatch

ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news. - Stockhead

ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news. Stockhead

Bone regeneration firm Osteopore moving into China with Shanghai-listed Kontour Xi’an - Market Index

Bone regeneration firm Osteopore moving into China with Shanghai-listed Kontour Xi’an Market Index

Osteopore International wins Made in Singapore – Medical award - Singapore Business Review

Osteopore International wins Made in Singapore – Medical award Singapore Business Review

Shares in regenerative medicine company Osteopore soar on Singapore, Vietnam market approvals - The West Australian

Shares in regenerative medicine company Osteopore soar on Singapore, Vietnam market approvals The West Australian

Osteopore International Pte Ltd clinches Made in Singapore Award for Medical - Singapore Business Review

Osteopore International Pte Ltd clinches Made in Singapore Award for Medical Singapore Business Review

Top Osteopore (Osx.Ax) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant